Positron emission tomography with <sup>18</sup>F‐fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer
Andrea M. McCollum(Centers for Disease Control and Prevention), Annick D. Van den Abbeele(Unknown), Charles M. Norris, Roy B. Tishler(Dana-Farber Cancer Institute), Robert I. Haddad(Georgetown University), Mary Ann Case(Dana-Farber Cancer Institute), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Steven Burrell(Harvard University)
Cited by 94
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926